期刊文献+

帕金森病患者躯体疲劳的临床调查分析 被引量:4

A Clinical Study of Physical Fatigue in Parkinson’s Disease Patients
原文传递
导出
摘要 目的:研究帕金森病(PD)患者伴躯体疲劳的分布情况及其相关因素。方法:运用帕金森病疲劳量表对113例原发性PD患者进行疲劳评估,并用统一PD评分量表、Hoehn-Yahr(分期、汉密尔顿焦虑量表、汉密尔顿抑郁量表、简易精神状态量表、帕金森睡眠量表、生活质量评分等量表对PD患者进行测定。结果:PD患者中,疲劳的发生率为41.6%,Logistic回归分析发现生活质量为疲劳的独立相关因素。结论:疲劳在PD患者中很普遍,明显影响患者生活质量。 Aim: To survey and investigate the prevalence of fatigue and its associated factors in Parkinson’s disease patients.Methods: 113 patients were assessed by Parkinson Fatigue Scale,Unified PD Rating Scale(UPDRS),Hoehn-Yahr(H-Y) stage,Hamilton Anxiety Scale(HAMA),Hamilton Depression Rating Scale(HRSD),Mini Mental State Examination(MMSE),Parkinson’s Disease Sleep Scale(PDSS),quality of life scores(PDQ-39).Results: The frequency of fatigue in PD patients was 41.6%,regression analysis showed that quality of life independently associated with fatigue.Conclusion: Fatigue is common in PD patients and affects the patients’ quality of life significantly.
出处 《中国临床神经科学》 2012年第1期61-66,共6页 Chinese Journal of Clinical Neurosciences
基金 上海交通大学医学院附属新华医院崇明分院院基金(编号:Y201019)及院重点扶持学科项目(编号:2011-YFC-07)资助
关键词 帕金森病 疲劳 生活质量 Parkinson’s disease fatigue quality of life
  • 相关文献

参考文献15

  • 1Bassetti CL.Nonmotor disturbances in Parkinson’s disease[J].Neurodegener Dis,2011,8:95-108.
  • 2Brown RG,Dittner A,Findley L,et al.The Parkinson fatigue scale[J].Parkinsonism Relat Disord,2005,11:49-55.
  • 3Grace T,Mendelsohn A,Friedman JH.A comparison of fatiguemeasures in Parkinson’s disease[J].Parkinsonism Relat Disord,2007,13:443-445.
  • 4沈黎玮,蒋雨平,耿道颖,李郁欣,朱珍.磁共振测量帕金森病患者基底节区、黑质体积的研究[J].中国临床神经科学,2005,13(3):273-278. 被引量:4
  • 5Folstein MF,Folstein SE,McHugh PR.“Mini-mental state”.Apractical method for grading the cognitive state of patients for theclinician[J].J Psychiatr Res,1975,12:189-198.
  • 6HAMILTON M.The assessment of anxiety states by rating[J].BrJ Med Psychol,1959,32:50-55.
  • 7Moreno RA,Moreno DA.Escalas de depressa o de Montgomery&Asberg(MADRS)e de Hamilton(HAM-D)[J].Rev Psiquiatr Clin,1998,25:262-272.
  • 8Chaudhuri KR,Pal S,DiMarco A,et a1.The Parkinson’s diseasesleep scale:a new instrument for assessing sleep and nocturnaldisability in Parkinson’s disease[J].J Neurol Neurosuig Psychiatry,2002,73:629-635.
  • 9Peto V,Jenkinson C,Fitzpatrick R,et al.PDQ-39:a review of thedevelopment,validation and application of a Parkinson’s diseasequality of life questionnaire and its associated measures[J].J Neurol,1998,245(Suppl.1):10-14.
  • 10丁正同,王坚,邬剑军,蒋雨平,刘楠,张克忠.恩他卡朋添加治疗症状波动的帕金森病的随机、双盲、安慰剂对照临床研究[J].中国临床神经科学,2005,13(1):91-95. 被引量:5

二级参考文献23

  • 1Agid Y,Olanow CW,Mizuno Y.Levodopa:why the controversy?[J].Lancet,2002,360:575.
  • 2Zappia M,Oliveri RL,Montesanti R,et al.Loss of long-duration response to levodopa over time in PD:implications for wearing-off[J].Neurology,1999,52:763-767.
  • 3Poewe WH,Deuschl G,Gordin A,et al.Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebocontrolled double-blind study in Germany and Austria (Celomen study)[J].Acta Neurol,Scand,2002,105:245-255.
  • 4Myllyla VV,Kultalahti ER,Haapaniemi H,et al.Twelve-month safety of entacapone in patients with Parkinson's disease[J].Eur J Neurol,2001,8:53-60.
  • 5Brooks DJ,Sagar H.Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease.[J].J Neurol Neurosurg,Psychiatry 2003,74:1064-1072.
  • 6Stocchi F,De Pandis MF,Vacca L,et al.Entacapone efficacy in Parkinson's disease[J].Mov Disord.2000,15(Suppl.3):127.
  • 7Nutt JG,Holford,NH.The response to levodopa in Parkinson's disease:imposing pharmacological law and order[J].Ann Neurol,1996.19:283-296.
  • 8Ruottinen HM,Rinne UK.A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease[J].Clin Neuropharmacol,1996,19:283-296.
  • 9Kaakkola S,Gordin A,Mannisto PT,General properties and clinical possibilities of new selective inhibitors of catechol-O-methyltransferase[J].Gen Pharmacol,1994,25:813-824.
  • 10Fe'nelon G,Gime'nez-Rolda'n S,Montastruc JL,et al.Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearingoff motor fluctuations.A randomized double-blind,multicentre study[J].Neural Transm,2003,110:239-251.

共引文献7

同被引文献61

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部